News

With funds from NIH, Chris Waters is studying the biomechanics of lung healing to help patients with Acute Respiratory Distress Syndrome (ARDS).

Professor Rick Honaker recently launched a pilot-scale processing plant aimed at recovering REEs from coal and its byproducts in Webster County.

A University of Kentucky study just published in Obstetrics & Gynecology shows that annual ultrasound screening of at-risk asymptomatic women increases the survival rates of women with type I and type II epithelial ovarian cancer.

Just one year after joining the Oncology Research Information Exchange Network (ORIEN), the University of Kentucky Markey Cancer Center has already enrolled more than 1,000 patients. ORIEN is an alliance of 19 major cancer centers that shares information to allow its members to push forward evidence-based cancer care to patients.

For the annual Board of Trustees retreat, UK President Eli Capilouto, VP for Research Lisa Cassis and Sharon Walsh, director of the Center on Drug & Alcohol Research, have framed an entire day of discussion and presentations around the opioid epidemic in the country and its specific impact on Kentucky.

The research building — funded half from the state of Kentucky and half from university resources, including private gifts — will house multidisciplinary research teams focusing on the Commonwealth’s most dire health disparities including cancer, diabetes and obesity, cardiovascular diseases and stroke and substance abuse.

A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.

This is the largest fundraising campaign in Kentucky's history. It will focus on funding more student scholarships and growing UK's endowment to continue support for providing a world-class education and essential research to address the state's most pressing challenges.

With funds from NIH, Barbara Nikolajczyk is tracking the trajectory of type 2 diabetes. She's following metabolically healthy people as they naturally progress to diabetes, looking for potential drug targets along the way.

Thanks to work being done at UK, pastures at an area horse farm are becoming healthier and so are their mares and foals.